Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure

NCT01961726 is registered in ClinicalTrials.gov with Juventas Therapeutics, Inc. as lead sponsor.

NCT NCT01961726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01961726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Lead sponsor
Juventas Therapeutics, Inc.
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2013
Completion date
August 31, 2015
Enrollment
72 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart failure